HEADER OXIDOREDUCTASE 21-AUG-07 2R0X TITLE CRYSTAL STRUCTURE OF A PUTATIVE FLAVIN REDUCTASE (YCDH, HS_1225) FROM TITLE 2 HAEMOPHILUS SOMNUS 129PT AT 1.06 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: POSSIBLE FLAVIN REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS SOMNUS 129PT; SOURCE 3 ORGANISM_TAXID: 205914; SOURCE 4 STRAIN: 129PT; SOURCE 5 GENE: YP_719437.1, YCDH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS SPLIT BARREL-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 7 25-JAN-23 2R0X 1 REMARK SEQADV REVDAT 6 24-JUL-19 2R0X 1 REMARK LINK REVDAT 5 25-OCT-17 2R0X 1 REMARK REVDAT 4 23-MAR-11 2R0X 1 HEADER TITLE KEYWDS REVDAT 3 24-FEB-09 2R0X 1 VERSN REVDAT 2 02-SEP-08 2R0X 1 ANISOU REVDAT 1 04-SEP-07 2R0X 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE FLAVIN REDUCTASE (YP_719437.1) JRNL TITL 2 FROM HAEMOPHILUS SOMNUS 129PT AT 1.06 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 54635 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : 0.141 REMARK 3 FREE R VALUE : 0.170 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2771 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.06 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.09 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3848 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2860 REMARK 3 BIN FREE R VALUE SET COUNT : 196 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1178 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 6.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.15000 REMARK 3 B22 (A**2) : 0.16000 REMARK 3 B33 (A**2) : 0.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.11000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.031 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.032 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.023 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.070 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.979 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.972 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1436 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 885 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1974 ; 1.667 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2192 ; 0.993 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 196 ; 7.287 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 56 ;35.212 ;24.821 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 226 ;11.103 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;18.543 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 232 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1682 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 275 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 261 ; 0.247 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 945 ; 0.210 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 701 ; 0.175 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 759 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 120 ; 0.158 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 24 ; 0.152 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 65 ; 0.275 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 27 ; 0.145 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 952 ; 2.236 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 358 ; 0.832 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1521 ; 3.080 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 533 ; 2.632 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 453 ; 3.523 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2497 ; 1.440 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 136 ;13.401 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2296 ; 5.840 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO REMARK 3 PARTIAL S-MET INCORPORATION. REMARK 3 3. UNEXPLAINED ELECTRON DENSITY NEAR RESIDUE 42 WAS REMARK 3 NOT MODELED. REMARK 3 4. ACETATE ION AND SULFATE ION FROM CRYSTALLIZATION REMARK 3 AND ETHYLENE GLYCOL (EDO) FROM CRYO SOLUTION REMARK 3 ARE MODELED. REMARK 4 REMARK 4 2R0X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-07. REMARK 100 THE DEPOSITION ID IS D_1000044288. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97925, 0.97898 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54635 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.060 REMARK 200 RESOLUTION RANGE LOW (A) : 23.402 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.3400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.67800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.340 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 29.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 2.0M AMMONIUM SULFATE, 0.1M REMARK 280 SODIUM ACETATE PH 4.6, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 36.01000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.42500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 36.01000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.42500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. CRYSTAL STRUCTURE PACKING SUGGESTS REMARK 300 THAT THE BIOLOGICALLY RELEVANT FORM IS A DIMER. REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF REMARK 300 A DIMER AS A SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8260 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -20.95310 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 43.67380 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 3 CD OE1 OE2 REMARK 470 GLN A 6 CD OE1 NE2 REMARK 470 LYS A 8 CE NZ REMARK 470 THR A 27 OG1 CG2 REMARK 470 LYS A 63 CD CE NZ REMARK 470 GLU A 90 CD OE1 OE2 REMARK 470 ASN A 142 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 40 -58.61 -121.20 REMARK 500 THR A 99 -157.15 -137.56 REMARK 500 LEU A 101 -94.11 -108.52 REMARK 500 LEU A 101 -93.60 -108.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 160 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 161 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 164 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 165 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 166 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 167 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 168 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 375038 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE FOLLOWED BY THE TARGET SEQUENCE. DBREF 2R0X A 11 157 UNP Q0I3S1 Q0I3S1_HAES1 1 147 SEQADV 2R0X GLY A 0 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X MSE A 1 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X VAL A 2 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X GLU A 3 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X VAL A 4 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X SER A 5 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X GLN A 6 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X PHE A 7 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X LYS A 8 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X ASP A 9 UNP Q0I3S1 EXPRESSION TAG SEQADV 2R0X ALA A 10 UNP Q0I3S1 EXPRESSION TAG SEQRES 1 A 158 GLY MSE VAL GLU VAL SER GLN PHE LYS ASP ALA MSE ALA SEQRES 2 A 158 GLN LEU ALA SER ALA VAL HIS ILE VAL THR THR SER GLY SEQRES 3 A 158 GLU THR GLY GLN HIS GLY PHE THR ALA SER ALA VAL CYS SEQRES 4 A 158 SER VAL THR ASP SER PRO PRO THR LEU LEU VAL CYS ILE SEQRES 5 A 158 ASN SER ASN ALA ARG ALA TYR GLU HIS PHE VAL LYS ASN SEQRES 6 A 158 ARG VAL LEU MSE VAL ASN THR LEU THR ALA GLU GLN SER SEQRES 7 A 158 SER LEU SER ASN ILE PHE ALA SER PRO LEU SER GLN GLU SEQRES 8 A 158 GLU ARG PHE SER ASN ALA SER TRP THR THR LEU THR THR SEQRES 9 A 158 GLY SER PRO MSE LEU GLN ASP ALA LEU ILE ASN PHE ASP SEQRES 10 A 158 CYS GLU ILE THR GLU ILE LYS HIS VAL GLY THR HIS ASP SEQRES 11 A 158 ILE LEU ILE CYS LYS ILE VAL ASP ILE HIS GLN SER ASN SEQRES 12 A 158 ALA LYS ASN ALA LEU VAL TYR ARG ASN ARG VAL TYR HIS SEQRES 13 A 158 SER VAL MODRES 2R0X MSE A 11 MET SELENOMETHIONINE MODRES 2R0X MSE A 68 MET SELENOMETHIONINE MODRES 2R0X MSE A 107 MET SELENOMETHIONINE HET MSE A 11 16 HET MSE A 68 8 HET MSE A 107 8 HET ACT A 158 4 HET ACT A 159 4 HET ACT A 160 4 HET ACT A 161 4 HET ACT A 162 4 HET SO4 A 163 10 HET SO4 A 164 5 HET SO4 A 165 5 HET EDO A 166 4 HET EDO A 167 8 HET EDO A 168 8 HETNAM MSE SELENOMETHIONINE HETNAM ACT ACETATE ION HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 3(C5 H11 N O2 SE) FORMUL 2 ACT 5(C2 H3 O2 1-) FORMUL 7 SO4 3(O4 S 2-) FORMUL 10 EDO 3(C2 H6 O2) FORMUL 13 HOH *135(H2 O) HELIX 1 1 GLU A 3 GLN A 13 1 11 HELIX 2 2 ALA A 57 ARG A 65 1 9 HELIX 3 3 GLN A 76 ALA A 84 1 9 HELIX 4 4 SER A 88 SER A 94 1 7 SHEET 1 A 3 SER A 16 ALA A 17 0 SHEET 2 A 3 ALA A 146 ARG A 150 -1 O TYR A 149 N SER A 16 SHEET 3 A 3 VAL A 153 VAL A 157 -1 O VAL A 157 N ALA A 146 SHEET 1 B 7 GLN A 29 ALA A 34 0 SHEET 2 B 7 HIS A 19 SER A 24 -1 N VAL A 21 O PHE A 32 SHEET 3 B 7 VAL A 66 THR A 71 -1 O ASN A 70 N ILE A 20 SHEET 4 B 7 ILE A 113 VAL A 125 -1 O CYS A 117 N LEU A 67 SHEET 5 B 7 HIS A 128 GLN A 140 -1 O HIS A 128 N VAL A 125 SHEET 6 B 7 THR A 46 ASN A 52 -1 N LEU A 47 O CYS A 133 SHEET 7 B 7 VAL A 37 THR A 41 -1 N CYS A 38 O LEU A 48 SHEET 1 C 2 TRP A 98 THR A 99 0 SHEET 2 C 2 MSE A 107 LEU A 108 -1 O MSE A 107 N THR A 99 SSBOND 1 CYS A 38 CYS A 38 1555 2556 2.21 LINK C ALA A 10 N AMSE A 11 1555 1555 1.33 LINK C ALA A 10 N BMSE A 11 1555 1555 1.32 LINK C AMSE A 11 N ALA A 12 1555 1555 1.33 LINK C BMSE A 11 N ALA A 12 1555 1555 1.33 LINK C LEU A 67 N MSE A 68 1555 1555 1.33 LINK C MSE A 68 N VAL A 69 1555 1555 1.33 LINK C PRO A 106 N MSE A 107 1555 1555 1.33 LINK C MSE A 107 N LEU A 108 1555 1555 1.33 CISPEP 1 SER A 43 PRO A 44 0 -10.33 CISPEP 2 SER A 43 PRO A 44 0 1.51 SITE 1 AC1 3 ASN A 52 HIS A 128 HOH A 169 SITE 1 AC2 2 TYR A 149 HOH A 301 SITE 1 AC3 3 GLU A 59 ARG A 152 HOH A 221 SITE 1 AC4 7 SER A 39 VAL A 40 THR A 41 ASP A 42 SITE 2 AC4 7 HIS A 128 HOH A 207 HOH A 210 SITE 1 AC5 6 GLY A 25 GLU A 26 THR A 27 HIS A 30 SITE 2 AC5 6 HIS A 60 ASN A 64 SITE 1 AC6 8 LYS A 123 HIS A 124 HIS A 155 SER A 156 SITE 2 AC6 8 HOH A 194 HOH A 233 HOH A 289 HOH A 303 SITE 1 AC7 8 GLY A 31 PHE A 32 ALA A 55 ARG A 56 SITE 2 AC7 8 ALA A 57 ARG A 92 HOH A 232 HOH A 261 SITE 1 AC8 10 HIS A 30 ARG A 56 HIS A 60 GLN A 89 SITE 2 AC8 10 HOH A 213 HOH A 223 HOH A 231 HOH A 264 SITE 3 AC8 10 HOH A 288 HOH A 290 SITE 1 AC9 5 ALA A 74 HIS A 124 HIS A 155 EDO A 167 SITE 2 AC9 5 HOH A 194 SITE 1 BC1 9 VAL A 62 ARG A 65 ALA A 74 GLU A 75 SITE 2 BC1 9 EDO A 166 HOH A 183 HOH A 222 HOH A 245 SITE 3 BC1 9 HOH A 246 SITE 1 BC2 7 VAL A 2 SER A 94 LYS A 134 HOH A 195 SITE 2 BC2 7 HOH A 208 HOH A 253 HOH A 260 CRYST1 72.020 38.850 48.440 90.00 115.63 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013880 0.000000 0.006660 0.00000 SCALE2 0.000000 0.025740 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022900 0.00000